IBDEI0NN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10808,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,10808,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,10809,0)
 ;;=C34.90^^68^675^114
 ;;^UTILITY(U,$J,358.3,10809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10809,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,10809,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,10809,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,10810,0)
 ;;=C65.9^^68^675^148
 ;;^UTILITY(U,$J,358.3,10810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10810,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,10810,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,10810,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,10811,0)
 ;;=C50.912^^68^675^129
 ;;^UTILITY(U,$J,358.3,10811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10811,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,10811,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,10811,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,10812,0)
 ;;=C50.911^^68^675^151
 ;;^UTILITY(U,$J,358.3,10812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10812,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,10812,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,10812,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,10813,0)
 ;;=C50.919^^68^675^121
 ;;^UTILITY(U,$J,358.3,10813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10813,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,10813,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,10813,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,10814,0)
 ;;=C62.90^^68^675^159
 ;;^UTILITY(U,$J,358.3,10814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10814,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,10814,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,10814,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,10815,0)
 ;;=D03.9^^68^675^161
 ;;^UTILITY(U,$J,358.3,10815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10815,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,10815,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,10815,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,10816,0)
 ;;=C45.0^^68^675^162
 ;;^UTILITY(U,$J,358.3,10816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10816,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,10816,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,10816,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,10817,0)
 ;;=C90.01^^68^675^164
 ;;^UTILITY(U,$J,358.3,10817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10817,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,10817,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,10817,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,10818,0)
 ;;=C90.00^^68^675^165
 ;;^UTILITY(U,$J,358.3,10818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10818,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,10818,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,10818,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,10819,0)
 ;;=C94.6^^68^675^166
 ;;^UTILITY(U,$J,358.3,10819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10819,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,10819,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,10819,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,10820,0)
 ;;=D61.82^^68^675^167
 ;;^UTILITY(U,$J,358.3,10820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10820,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,10820,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,10820,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,10821,0)
 ;;=D47.9^^68^675^168
 ;;^UTILITY(U,$J,358.3,10821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10821,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
